FAM76B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.57230001135633E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.69749999507007E-08 |
Normal-vs-Stage2 |
1.939980E-03 |
Normal-vs-Stage3 |
1.90055999998995E-05 |
Normal-vs-Stage4 |
4.35400000000641E-05 |
Stage1-vs-Stage2 |
4.745400E-01 |
Stage1-vs-Stage3 |
7.359400E-01 |
Stage1-vs-Stage4 |
6.772400E-01 |
Stage2-vs-Stage3 |
3.961800E-01 |
Stage2-vs-Stage4 |
3.660200E-01 |
Stage3-vs-Stage4 |
9.166200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.31640000011757E-08 |
Normal-vs-AfricanAmerican |
7.360900E-04 |
Normal-vs-Asian |
3.43910000000225E-06 |
Caucasian-vs-AfricanAmerican |
9.183000E-01 |
Caucasian-vs-Asian |
7.456400E-02 |
AfricanAmerican-vs-Asian |
9.366200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.59230000296162E-08 |
Normal-vs-Female |
2.77399999970562E-07 |
Male-vs-Female |
7.985400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.269770E-02 |
Normal-vs-Age(41-60Yrs) |
1.26209998008164E-09 |
Normal-vs-Age(61-80Yrs) |
1.96860000001298E-06 |
Normal-vs-Age(81-100Yrs) |
8.706300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.331400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.279600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.999200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.147700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.126100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.728000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.2169999999978E-06 |
Normal-vs-Grade 2 |
1.53110002454326E-09 |
Normal-vs-Grade 3 |
1.68973999999933E-05 |
Normal-vs-Grade 4 |
1.275630E-02 |
Grade 1-vs-Grade 2 |
1.962450E-01 |
Grade 1-vs-Grade 3 |
1.878400E-02 |
Grade 1-vs-Grade 4 |
1.196490E-02 |
Grade 2-vs-Grade 3 |
1.300430E-02 |
Grade 2-vs-Grade 4 |
4.122900E-03 |
Grade 3-vs-Grade 4 |
2.200000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.85190032384742E-10 |
Normal-vs-ccB subtype |
3.71369999999649E-05 |
ccA subtype-vs-ccB subtype |
1.588450E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.15500000008595E-07 |
Normal-vs-N1 |
1.017550E-01 |
N0-vs-N1 |
3.663600E-01 |
|
|